A more recent surfaceome analyses revealed many new Ewing sarcoma cell surface targets including ENPP1 and CDH11 in addition to known IL1RAP, STEAP1, ADGRG2 and CD99, providing newer cell surface targets for immunotherapeutic application in Ewing sarcoma [325]. This evidence concerns the gene CD99 and Ewing sarcoma.